查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540782

2024-2032 年按产品、分析类型、技术、最终用户和地区分類的细胞分析市场报告

Cell Analysis Market Report by Product, Analysis Type, Techniques, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球细胞分析市场规模达207亿美元。向个人化医疗的转变、全球癌症病例的增加以及人工智慧和机器学习在细胞分析中的日益融合是催化市场成长的一些关键因素。

细胞分析市场分析：

主要市场驱动因素：药物发现和开发中对细胞分析工具的需求不断增加，特别是在肿瘤学和免疫学等领域，是市场成长的主要动力。癌症和自体免疫疾病等慢性疾病的盛行率不断上升，增加了对用于疾病诊断和治疗的先进细胞分析技术的需求，这也促进了市场的成长。

主要市场趋势：再生医学和干细胞研究的扩展增加了对细胞分析工具来研究细胞行为、分化和治疗应用的需求，这为整个市场创造了积极的前景。

竞争格局：全球市场上一些领先的细胞分析公司包括 Agilent Technologies Inc.、BD Biosciences、Bio-RAD Laboratories Inc.、Danaher Corporation、Illumina Inc.、Merck KGaA、Miltenyi Biotec、Olympus Corporation、PerkinElmer Inc.。公司、Sysmex 公司和Thermo Fisher Scientific 等。

地理趋势：根据报告，北美目前在全球市场上占据主导地位。该地区的增长可归因于癌症发病率的增加以及企业和政府对细胞研究活动的资助不断增加。

挑战与机会：挑战包括解释大规模资料的复杂性、在分析过程中维持细胞活力以及先进技术的高成本。机会在于扩大个人化医疗、再生疗法的应用，以及人工智慧的整合以增强分析能力和简化流程。

全球细胞分析市场趋势：

癌症负担日益加重

全球癌症病例数量的增加主要推动了市场的成长。癌症研究中的细胞分析工具和技术能够精确地表征肿瘤细胞，包括其基因突变、蛋白质表现谱以及肿瘤微环境中的细胞交互作用。癌症患者数量的不断增加正在推动细胞分析市场份额的成长。例如，根据美国癌症协会 2022 年更新，预计 2022 年美国将新增约 1,918,030 例癌症病例。加拿大癌症协会（CCS）表示，2020年，近29,800名加拿大人被诊断出罹患肺癌，占所有新发癌症病例的13%。预计约 21,200 名加拿大人将死于肺癌，占 2020 年所有癌症死亡人数的 25%。因此，对有效和持久的癌症治疗的需求不断增长，预计将为整个市场提供利润丰厚的成长机会。

新型分子的不断发展

各种传染病病率的上升正在促进新型分子和疫苗的开发，这反过来又增加了细胞分析市场的收入。细胞分析工具使研究人员能够评估潜在候选药物的功效、安全性和作用机制，在药物发现和开发中发挥至关重要的作用。此外，各种製药和生物技术公司越来越依赖细胞分析技术和工具来推出新的和改进的药物。例如，根据美国国会预算办公室公布的资料，2021年，全球製药业在研发上的支出接近2,000亿美元，而2019年为8,300万美元。的研发投资为17.42 亿美元，而2020 年为13.48 亿美元。进一步提高了公司采用创新细胞分析技术的能力，从而推动细胞分析市场的成长。

策略合作和收购数量不断增加

各个主要市场参与者正在建立伙伴关係和协作，以开发新的和改进的细胞分析方法、工具和技术。例如，2022 年 8 月，屡获殊荣的 CellDrop 自动细胞计数器的製造商 DeNovix Inc. 开发了两款专用的细胞核计数应用程序，能够区分分离的细胞核和完整的细胞与碎片。 CellDrop 系列是一系列以影像为基础的自动化细胞计数器。系统包括高清 7 吋触控屏，用于即时预览和即时查看结果。同样，2022年11月，索尼公司推出了SFA——生命科学云平台，这是一种流式细胞仪资料分析云解决方案，可以利用获得的资料快速识别各种细胞群体中的稀有细胞，例如癌细胞和干细胞。除此之外，2022 年 3 月，Thermo Fisher Scientific 推出了一种新型大容量电穿孔系统，旨在促进细胞疗法的开发。预计此类创新将在未来几年提振细胞分析市场的需求。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球细胞分析市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 流式细胞仪产品
    • 市场趋势
    • 市场预测
  • 定量PCR产品
    • 市场趋势
    • 市场预测
  • 细胞微阵列
    • 市场趋势
    • 市场预测
  • 显微镜
    • 市场趋势
    • 市场预测
  • 分光光度计
    • 市场趋势
    • 市场预测
  • 细胞计数器
    • 市场趋势
    • 市场预测
  • HCS系统
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按分析类型

  • 细胞识别
    • 市场趋势
    • 市场预测
  • 细胞活力
    • 市场趋势
    • 市场预测
  • 细胞讯号传导途径/讯号传导
    • 市场趋势
    • 市场预测
  • 细胞增殖
    • 市场趋势
    • 市场预测
  • 细胞计数和品质控制
    • 市场趋势
    • 市场预测
  • 细胞交互作用
    • 市场趋势
    • 市场预测
  • 目标识别和验证
    • 市场趋势
    • 市场预测
  • 单细胞分析
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依技术

  • 分子方法
    • 市场趋势
    • 市场预测
  • 基于影像的方法
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 製药和生物技术公司和 CRO
    • 市场趋势
    • 市场预测
  • 医院和诊断实验室
    • 市场趋势
    • 市场预测
  • 研究所
    • 市场趋势
    • 市场预测
  • 细胞培养物保藏库
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • BD Biosciences
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Merck KGaA
    • Miltenyi Biotec
    • Olympus Corporation
    • PerkinElmer Inc.
    • Promega Corporation
    • Sysmex Corporation
    • Thermo Fisher Scientific
Product Code: SR112024A2200

The global cell analysis market size reached US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. The shift towards personalized medicine, increasing cases of cancer across the globe, and growing integration of artificial intelligence and machine learning in cell analysis are some of the key factors, catalyzing the growth of the market.

Cell Analysis Market Analysis:

Major Market Drivers: Increasing demand for cell analysis tools in drug discovery and development, particularly in fields like oncology and immunology, is primarily driving the market growth. The rising prevalence of chronic diseases like cancer and autoimmune disorders is augmenting the need for advanced cell analysis techniques for disease diagnosis and treatment, which is also contributing to the market growth.

Key Market Trends: The expansion of regenerative medicine and stem cell research is augmenting the need for cell analysis tools to study cell behavior, differentiation, and therapeutic applications, which is creating a positive outlook for the overall market.

Competitive Landscape: Some of the leading cell analysis companies operating in the global market include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, and Thermo Fisher Scientific, among others.

Geographical Trends: According to the report, North America currently dominates the global market. The growth of the region can be attributed to the increase in incidences of cancer and rising corporate and government funding in cell-based research activities.

Challenges and Opportunities: Challenges include the complexity of interpreting large-scale data, maintaining cell viability during analysis, and the high cost of advanced technologies. Opportunities lie in expanding applications in personalized medicines, regenerative therapies, and the integration of artificial intelligence to enhance analytical capabilities and streamline processes.

Global Cell Analysis Market Trends:

Growing Burden of Cancer

The rising number of cancer cases across the world is primarily driving the market growth. Cell analysis tools and techniques in cancer research enable precise characterization of tumor cells, including their genetic mutations, protein expression profiles, and cellular interactions within the tumor microenvironment. The growing number of cancer patients is catalyzing the cell analysis market share. For instance, as per an American Cancer Society 2022 update, around 1,918,030 new cancer cases were estimated in the U.S. in 2022. Furthermore, lung cancer and breast cancer are two of the most common cancers found among individuals. The Canadian Cancer Society (CCS) stated that in 2020, nearly 29,800 Canadians were diagnosed with lung cancer, which accounted for 13% of all new cancer cases. About 21,200 Canadians were expected to die from lung cancer, which represented 25% of all cancer deaths in 2020. This indicates an inflating need for effective and more advanced cancer cell analysis. Thus, the increasing demand for effective and lasting cancer treatment is anticipated to offer lucrative growth opportunities to the overall market.

Increasing Development of Novel Molecules

The rising prevalence of various infectious diseases is prompting the development of novel molecules and vaccines, which in turn is augmenting the cell analysis market revenue. Cell analysis tools play a crucial role in drug discovery and development by enabling researchers to assess the efficacy, safety, and mechanism of action of potential drug candidates. Furthermore, various pharmaceutical and biotech firms are increasingly relying on cell analysis techniques and tools to introduce new and improved drugs. For instance, according to the data published by the Congressional Budget Office, in 2021, it was observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally, compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1,742 million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc., invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Thus, the rising investment in research and development by the companies further increases the capabilities of the company to adopt innovative cell analysis techniques, thereby propelling the cell analysis market growth.

Rising Number of Strategic Collaborations and Acquisitions

Various key market players are forming partnerships and collaborations to develop new and improved cell analysis methods, tools, and techniques. For instance, in August 2022, DeNovix Inc., the manufacturer of the award-winning CellDrop Automated Cell Counter, developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris. The CellDrop Series is a line of image-based, automated cell counters. Systems include a high-definition 7-inch touchscreen for live preview and instant review of results. Similarly, in November 2022, Sony Corporation launched the SFA - Life Sciences Cloud Platform, a flow cytometry data analysis cloud solution that can quickly identify rare cells, such as cancer cells and stem cells, from a wide variety of cell populations, using data obtained from flow cytometers. In addition to this, in March 2022, Thermo Fisher Scientific introduced a new large-volume electroporation system that is intended to enable the development of cell therapies. Such innovations are expected to bolster the cell analysis market demand in the coming years.

Global Cell Analysis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cell analysis market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, analysis type, techniques, and end-user.

Breakup by Product:

Flow Cytometry Products

qPCR Products

Cell Microarrays

Microscopes

Spectrophotometers

Cell Counters

HCS Systems

Others

Flow cytometry products exhibit a clear dominance in the market

The cell analysis market report has provided a detailed breakup and analysis of the market based on the product. This includes flow cytometry products, qPCR Products, cell microarrays, microscopes, spectrophotometers, cell counters, HCS systems, and others. According to the report, flow cytometry products exhibit a clear dominance in the market.

Flow cytometry products are pivotal in the cell analysis market, offering precise quantification and characterization of cells based on their physical and chemical properties. Key components include flow cytometers, which analyze cells in fluid suspension using lasers to detect fluorescently labeled cells. Reagents such as fluorescent dyes and antibodies enable specific labeling for biomarker detection, while software facilitates data analysis and visualization. These products are essential in research, clinical diagnostics, and drug discovery, providing insights into cell function, differentiation, and disease mechanisms. Ongoing advancements in technology are enhancing sensitivity, multiplexing capabilities, and automation, expanding the utility of flow cytometry in diverse biomedical applications.

Breakup by Analysis Type:

Cell Identification

Cell Viability

Cell Signaling Pathways/Signal Transduction

Cell Proliferation

Cell Counting and Quality Control

Cell Interaction

Target Identification and Validation

Single-Cell Analysis

Others

Cell identification analysis type holds the majority of the total market share

The cell analysis market research report has provided a detailed breakup and analysis of the market based on the analysis type. This includes cell identification, cell viability, cell signaling pathways/signal transduction, cell proliferation, cell counting and quality control, cell interaction, target identification and validation, single-cell analysis, and others. According to the report, cell identification analysis type holds the majority of the total market share.

Cell identification in cell analysis involves various techniques to distinguish and classify cells based on their morphological, molecular, or functional characteristics. Methods include microscopy for visual inspection, flow cytometry for quantitative analysis of cell surface markers, and molecular techniques like PCR for genetic profiling. Immunohistochemistry and immunofluorescence enable detection of specific proteins within tissues or cell samples. Advances in single-cell analysis technologies allow for high-resolution characterization of individual cells within heterogeneous populations. Accurate cell identification is crucial in understanding disease mechanisms, assessing treatment responses, and advancing personalized medicine by tailoring therapies based on individual cell profiles.

Breakup by Techniques:

Molecular Approaches

Image-Based Approaches

Molecular approaches represent the largest market share

The report has provided a detailed breakup and analysis of the market based on the techniques. This includes molecular approaches and image-based approaches. According to the report, molecular approaches represent the largest market share.

Molecular approaches in cell analysis focus on studying cellular components at the molecular level to understand biological processes and diseases. Techniques include PCR (Polymerase Chain Reaction) for amplifying and detecting DNA or RNA sequences, Western blotting for protein detection and quantification, and next-generation sequencing (NGS) for comprehensive genomic analysis. These methods enable researchers to investigate gene expression, mutations, protein interactions, and epigenetic modifications within cells. Molecular approaches are vital in biomarker discovery, drug development, and personalized medicine, offering insights into cellular function and disease mechanisms with high sensitivity and specificity. Continued advancements enhance their utility in diverse biomedical research applications.

Breakup by End-User:

Pharmaceutical and Biotechnology Companies and CROs

Hospitals and Diagnostic Laboratories

Research Institutes

Cell Culture Collection Repositories

Others

Pharmaceutical and biotechnology companies and CROs currently account for the majority of the total market share

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes pharmaceutical and biotechnology companies and CROs, hospitals and diagnostic laboratories, research institutes, cell culture collection repositories, and others. According to the report, pharmaceutical and biotechnology companies and CROs currently account for the majority of the total market share.

Pharmaceutical and biotechnology companies develop and commercialize drugs and therapies for medical use. They conduct extensive research and clinical trials to discover new compounds, validate their efficacy and safety, and obtain regulatory approvals. Contract Research Organizations (CROs) support these efforts by providing specialized, such as clinical trial management, data analysis, and regulatory compliance. CROs enable companies to outsource non-core activities, accelerate timelines, and manage costs effectively. Furthermore, the increasing rate of new drug development is also contributing to the segment's growth. For instance, between 2010 and 2019, around 38 new drugs were approved each year, on an average. That is about a 60% increase compared with the previous decade. Drug approvals reached a new peak in 2018, surpassing the record number of approvals of the late 1990s. The cell analysis market statistics by IMARC indicate that together, pharmaceutical/biotech firms and CROs are playing crucial roles in advancing healthcare innovation, bringing new treatments to market, and improving patient outcomes through rigorous scientific research and development.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America currently dominates the global market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

The growth of the region can be attributed to the increase in incidences of cancer and rising corporate and government funding in cell-based research. For instance, according to the Canadian Cancer Statistics 2022 Special Report, the number of people living with and after cancer in Canada continued to grow to over 1.5 million people. Additionally, according to another report, 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime. Approximately 1 in 4 Canadians is expected to die of the disease. Besides this, the presence of major companies, the growing number of product launches, and the strong R&D in biotechnology are further positively impacting the cell analysis market outlook. For instance, in September 2022, Becton, Dickinson, and Company launched BD Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher-quality experiments with faster time to insight for scientists working across a range of disciplines, including immunology, virology, oncology, and infectious disease monitoring.

Competitive Landscape:

The competitive landscape of the industry has also been examined with the detailed profiles of the following key players:

Agilent Technologies Inc.

BD Biosciences

Bio-RAD Laboratories Inc.

Danaher Corporation

Illumina Inc.

Merck KGaA

Miltenyi Biotec

Olympus Corporation

PerkinElmer Inc.

Promega Corporation

Sysmex Corporation

Thermo Fisher Scientific

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Global Cell Analysis Market News:

June 2024: Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the launch of the ddSEQ(TM) Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.

March 2024: US-headquartered Cytek Biosciences, Inc., opened a new 50,000-square-foot facility in Wuxi, China. This strategic move increases the company's manufacturing capacity to meet the growing worldwide demand for comprehensive cell analysis solutions.

February 2024: 10x Genomics, Inc., a leader in single-cell and spatial biology, announced the launch of GEM-X, the next generation of the company's leading single-cell technology. GEM-X is built on a new and improved microfluidic chip design, featuring the latest technological advancements and optimized reagents for superior performance and high reliability.

Key Questions Answered in This Report

  • 1. What was the size of the global cell analysis market in 2023?
  • 2. What is the expected growth rate of the global cell analysis market during 2024-2032?
  • 3. What are the key factors driving the global cell analysis market?
  • 4. What has been the impact of COVID-19 on the global cell analysis market?
  • 5. What is the breakup of the global cell analysis market based on the product?
  • 6. What is the breakup of the global cell analysis market based on the analysis type?
  • 7. What is the breakup of the global cell analysis market based on the techniques?
  • 8. What is the breakup of the global cell analysis market based on the end-user?
  • 9. What are the key regions in the global cell analysis market?
  • 10. Who are the key players/companies in the global cell analysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell Analysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Flow Cytometry Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 qPCR Products
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cell Microarrays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Microscopes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Spectrophotometers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Cell Counters
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 HCS Systems
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Analysis Type

  • 7.1 Cell Identification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cell Viability
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cell Signaling Pathways/Signal Transduction
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cell Proliferation
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cell Counting and Quality Control
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Cell Interaction
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Target Identification and Validation
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Single-Cell Analysis
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Others
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast

8 Market Breakup by Techniques

  • 8.1 Molecular Approaches
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Image-Based Approaches
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Pharmaceutical and Biotechnology Companies and CROs
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cell Culture Collection Repositories
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 BD Biosciences
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Illumina Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Miltenyi Biotec
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Olympus Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 PerkinElmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Promega Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sysmex Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cell Analysis Market: Major Drivers and Challenges
  • Figure 2: Global: Cell Analysis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cell Analysis Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Cell Analysis Market: Breakup by Analysis Type (in %), 2023
  • Figure 5: Global: Cell Analysis Market: Breakup by Techniques (in %), 2023
  • Figure 6: Global: Cell Analysis Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Cell Analysis Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cell Analysis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Cell Analysis (Flow Cytometry Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cell Analysis (Flow Cytometry Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cell Analysis (qPCR Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cell Analysis (qPCR Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cell Analysis (Cell Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cell Analysis (Cell Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cell Analysis (Microscopes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cell Analysis (Microscopes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cell Analysis (Spectrophotometers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cell Analysis (Spectrophotometers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cell Analysis (Cell Counters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cell Analysis (Cell Counters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cell Analysis (HCS Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cell Analysis (HCS Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cell Analysis (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cell Analysis (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cell Analysis (Cell Identification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cell Analysis (Cell Identification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cell Analysis (Cell Viability) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cell Analysis (Cell Viability) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cell Analysis (Cell Signaling Pathways/Signal Transduction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cell Analysis (Cell Signaling Pathways/Signal Transduction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Cell Analysis (Cell Proliferation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Cell Analysis (Cell Proliferation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Cell Analysis (Cell Counting and Quality Control) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Cell Analysis (Cell Counting and Quality Control) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Cell Analysis (Cell Interaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Cell Analysis (Cell Interaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Cell Analysis (Target Identification and Validation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Cell Analysis (Target Identification and Validation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Cell Analysis (Single-Cell Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Cell Analysis (Single-Cell Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Cell Analysis (Other Analysis Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Cell Analysis (Other Analysis Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Cell Analysis (Molecular Approaches) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Cell Analysis (Molecular Approaches) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Cell Analysis (Image-Based Approaches) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Cell Analysis (Image-Based Approaches) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Cell Analysis (Pharmaceutical and Biotechnology Companies and CROs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Cell Analysis (Pharmaceutical and Biotechnology Companies and CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Cell Analysis (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Cell Analysis (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Cell Analysis (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Cell Analysis (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Global: Cell Analysis (Cell Culture Collection Repositories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Global: Cell Analysis (Cell Culture Collection Repositories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Global: Cell Analysis (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Global: Cell Analysis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: North America: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: North America: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United States: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United States: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Canada: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Canada: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Asia Pacific: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Asia Pacific: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: China: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: China: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Japan: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Japan: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: India: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: India: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: South Korea: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: South Korea: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Australia: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Australia: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Indonesia: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Indonesia: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Europe: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Europe: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Germany: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Germany: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: France: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: France: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: United Kingdom: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: United Kingdom: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Italy: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Italy: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Spain: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Spain: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Russia: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Russia: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Others: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Others: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Latin America: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Latin America: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Brazil: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Brazil: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Mexico: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Mexico: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 101: Others: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 102: Others: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 103: Middle East and Africa: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 104: Middle East and Africa: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 105: Global: Cell Analysis Industry: SWOT Analysis
  • Figure 106: Global: Cell Analysis Industry: Value Chain Analysis
  • Figure 107: Global: Cell Analysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell Analysis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cell Analysis Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Cell Analysis Market Forecast: Breakup by Analysis Type (in Million US$), 2024-2032
  • Table 4: Global: Cell Analysis Market Forecast: Breakup by Techniques (in Million US$), 2024-2032
  • Table 5: Global: Cell Analysis Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Cell Analysis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cell Analysis Market: Competitive Structure
  • Table 8: Global: Cell Analysis Market: Key Players